Matching-adjusted indirect comparison of phase 3 clinical trial outcomes of OC-01 (varenicline solution) nasal spray and lifitegrast 5% ophthalmic solution for the treatment of dry eye disease

White, DE; Hendrix, LH; Sun, LCL; Tam, I; Macsai, M; Gibson, AA

Gibson, AA (通讯作者),Oyster Point Pharm Inc, Princeton, NJ 08540 USA.

JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2023; 29 (1): 69